461 related articles for article (PubMed ID: 19631377)
1. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.
Acharya S; Dilnawaz F; Sahoo SK
Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377
[TBL] [Abstract][Full Text] [Related]
2. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
Mo Y; Lim LY
J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
[TBL] [Abstract][Full Text] [Related]
5. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
6. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy.
Das M; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2011 Apr; 6(3):489-507. PubMed ID: 21542687
[TBL] [Abstract][Full Text] [Related]
7. Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
McCarron PA; Marouf WM; Quinn DJ; Fay F; Burden RE; Olwill SA; Scott CJ
Bioconjug Chem; 2008 Aug; 19(8):1561-9. PubMed ID: 18627195
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
10. Trastuzumab guided nanotheranostics: A lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy.
Parhi P; Sahoo SK
J Colloid Interface Sci; 2015 Aug; 451():198-211. PubMed ID: 25897856
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
Kocbek P; Obermajer N; Cegnar M; Kos J; Kristl J
J Control Release; 2007 Jul; 120(1-2):18-26. PubMed ID: 17509712
[TBL] [Abstract][Full Text] [Related]
13. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.
Sahoo SK; Labhasetwar V
Mol Pharm; 2005; 2(5):373-83. PubMed ID: 16196490
[TBL] [Abstract][Full Text] [Related]
15. Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy.
Acharya S; Sahoo SK
Biomaterials; 2011 Aug; 32(24):5643-62. PubMed ID: 21600647
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
[TBL] [Abstract][Full Text] [Related]
17. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
[TBL] [Abstract][Full Text] [Related]
18. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
Misra R; Sahoo SK
Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]